Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


JAMA Identifies Challenges For Diagnostic AI

Executive Summary

An article in the Journal of the American Medical Association outlines challenges for clinical decision AI software in its current state.

You may also be interested in...

Chatbots Are Not Ready To Be Medical Devices, Experts Argue

Commentary from an article in Nature explores the challenge to regulating chatbots as medical devices.

Report Finds Most FDA-Approved AI Devices Are Used For Imaging

The pace of artificial intelligence development has accelerated in recent years and now most of the artificial intelligence devices approved by the FDA are imaging devices.

NAM’S Health Care AI Development Code Of Conduct Addresses Gaps In Current Principles

The National Academy of Medicine developed a code of conduct for health care AI development, as well as commitments for code implementation. 


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts